Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma.

Zhang, Yuan; Chen, Jianbo; Zhao, Yunan; Weng, Lihong; Xu, Yiquan

Zhang, Yuan; Chen, Jianbo; Zhao, Yunan; Weng, Lihong; Xu, Yiquan.

Afiliação

Zhang Y; The First Affiliated Hospital of Xiamen University, Xiamen, China.
Chen J; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Clinical Medicine, Fujian Medical University, Xiamen, China.
Zhao Y; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Weng L; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Xu Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Xiamen University, Xiamen, China.

Front Oncol ; 10: 562574, 2020.

Article em En | MEDLINE | ID: mdl-33194633

Palavras-chave

ceramide pathway; consensus clustering; lung adenocarcinoma; prognostic risk signature; tumor immune microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google